DiviDrip · CSTL

CSTL — Castle Biosciences, Inc.

CSTL is Castle Biosciences, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $32.65. Market cap: $997M. Capital Quality Rank: 89/100 — Elite compounder.

Stock snapshot

Price$32.65
Market cap$997M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)89 / 100 · Elite compounder
ROIC (TTM)-9.3%
Revenue CAGR (3y)35.9%
Shareholder buyback yield0.93%
Altman Z-score zoneSafe

About CSTL

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Listed2019Employees1.0KHQFriendswood, TXSectorHealthcareWebsitecastlebiosciences.com

Related non-dividend companies

Other non-dividend stocks investors research alongside CSTL. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is CSTL's current stock price?

CSTL (Castle Biosciences, Inc.) is currently trading at $32.65.

Does CSTL pay a dividend?

CSTL (Castle Biosciences, Inc.) does not currently pay a regular dividend.

What is CSTL's Capital Quality Rank?

CSTL has a Capital Quality Rank of 89/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track CSTL in DiviDrip

Add CSTL to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow